New Targets in the Fight against Cancer

Cancer behaviour is highly complex. Tumour cells are adept at evading the body’s defence mechanisms and therapeutic drugs over time. At Mater Dei Hospital, a multidisciplinary team of health professionals is analysing a rare case of cancer cell transformation that may uncover new therapeutic approaches for patients with this cancer type.

Continue reading

ALS Discoveries that Help Unlock New Treatments

Amyotrophic Lateral Sclerosis (ALS) is a rare neurodegenerative disease that ‘locks’ patients in their own bodies, clear-headed but unable to move or speak. A research group at the University of Malta is looking for therapeutic targets to treat the disease while supporting ALS patients and their families through their condition.

Continue reading

What a trip, man.

Psychedelics conjure images of hippies and tie-dye, or they may trigger images of junkies and erratic behaviours. However, psychedelic drugs are gaining a reputation as possible therapies for many psychiatric disorders, and researchers are not shy about praising their benefits. Meanwhile, psychedelics are illegal in most countries, deemed dangerous, and their use socially condemned. THINK explores the ambiguity behind this class of drugs.

Continue reading

What COVID-19 has taught us about education

While sitting in my living room and staring at a computer screen split into 4 squares (each with its own head), I talked with Dr Charmaine Bonello, Dr Tania Muscat and Dr Josephine Deguara from the Department of Early Childhood and Primary Education (DECPE), at the University of Malta (UM). I was curious about the changes in the education system during the pandemic. While the pandemic has allowed some of us to work from home, the education sector has faced certain challenges.  I talked with the three researchers about how the pandemic has affected the education system, with a focus on five particular stakeholders in Early and Primary Education.

Continue reading